Results

Thirty–six (36) participants (60±8.7 years old, 21 female) with moderate–to–severe KOA received an average of 4.3±0.7 prolotherapy injection sessions over a 17–week treatment period and reported progressively improved scores during the 52–week study on WOMAC and KPS measures.